Sandoz (Generics)
Delivering affordable, high-quality medicines
Sandoz, the generic pharmaceuticals division of Novartis, is a global industry leader, offering affordable, high-quality medicines to everyone, everywhere. It is the second-largest division of Novartis.
2010 net sales - USD 8.5 billion
Sandoz develops and produces approximately 1 000 compounds, as well as active substances and intermediates. Our operations span five continents, and we market products in about 130 countries.
In addition to its retail generics business, Sandoz operates three businesses that focus on anti-infectives, oncology injectables and biopharmaceuticals.
Not all products or indications are available in all countries. Regulatory requirements in various countries limit the product information that we can provide. Please consult your healthcare professional about any medical condition or product.
Key marketed products (retail generics):
| Product | Originator* | Drug Description |
|---|---|---|
| Omeprazole | Prilosec® (Procter & Gamble) |
Ulcer and heartburn treatment |
| Amoxicillin / clavulanic acid | Augmentin® (GlaxoSmithKline) |
Anti-infective |
| Fentanyl | Duragesic® (Ortho-McNeil-Janssen Pharmaceuticals) |
Analgesic |
| Amlodipine / Benazepril | Lotrel | Antihypertensive |
| Simvastatin | Zocor® (Merck & Co) |
Cholesterol-lowering treatment |
| Acetylsteine | Fluimucil® | Respiratory system |
| Tacrolimus | Prograf® (Astellas) |
Transplantation |
| Enoxaparin sodium injection | Lovenox® | Anti-coagulant |
| Lansoprazole | Prevacid® | Proton pump inhibitor |
| Losartan/Losartan HCT | Cozaar®/Hyzaar® | Hypertension |
- *Product names identified by a "®" are trademarks that are not owned by or licensed to the Novartis Group of companies.
